Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia

IntroductionInduction intravesical Bacillus Calmette-Guerin (BCG) followed by maintenance after transurethral resection of bladder tumor, is the standard adjuvant therapy for high-risk non-muscle invasive bladder cancer (NMIBC). There is sparse evidence on the practice of intravesical BCG in Austral...

詳細記述

書誌詳細

出版年:	Frontiers in Urology
主要な著者:	Chamodi Pillippu Hewa, Stephen Della-Fiorentina, Kayvan Haghighi, Wei Chua, Peey-Sei Kok
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2024-02-01
主題:	intravesical BCG NMIBC disease-free survival bladder cancer TURBT overall survival
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fruro.2024.1309532/full